Experience

和誉医药

• China
• Biotechnology Research
• 1 - 100 Employee

• Associate Director, Clinical Pharmacology

  • Apr 2022 - Present



BeiGene

• United States
• Biotechnology Research
• 700 & Above Employee

• Principal Clinical Pharmacologist

  • Mar 2021 - Apr 2022

  1. ClinPharm lead for ZW25/ZW49/AMG510/Blincyto in BeiGene;2. ClinPharm lead for a in-house bispecifc antibody;3. Oversee APAC pharmacometrics analysis in BeiGene and developed BeiGene Pharmacometrics process and guidance;4. Due dilligence for serveral BD activities;

• Senior Clinical Pharmacologist

  • Feb 2020 - Feb 2021

  1. ClinPharm lead for ZW25/ZW49/AMG510/Blincyto in BeiGene;2. ClinPharm lead for a in-house bispecifc antibody;3. Oversee APAC pharmacometrics analysis in BeiGene and developed BeiGene Pharmacometrics process and guidance;4. Due dilligence for serveral BD activities



The Janssen Pharmaceutical Companies of Johnson & Johnson

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Clinical Pharmacologist&Pharmacometrician

  • Sep 2018 - Feb 2020

  1. Clinical Pharmacology Lead for erdafitinib, teclistamab and niraparib. 2. Pharmacometrics Lead for erdafitinib and esketamine. 1. Clinical Pharmacology Lead for erdafitinib, teclistamab and niraparib. 2. Pharmacometrics Lead for erdafitinib and esketamine.



Amgen

• United States
• Biotechnology Research
• 700 & Above Employee

• Pharmacometrician

  • Jun 2016 - Sep 2018

  1. Develop population PK/PD modeling to evaluate the ethnic difference of evolocumab;2. Perform pharmacometrics analysis to quantify bone turnover markers as surrogate endpoint in postmenopausal osteoporosis treatment of denosumab.

• Statistician

  • Jun 2016 - Sep 2018

  1. Develop Archimedean copula models for semi-competing risks data；2. Develop code to simulate basket design, including population selection and multiple testing;3. Participate ALL RWE study to support Blincyto Phase III study. Take responsibility for statistic, paper writing and review.